The Meals and Drug Administration’s approval of Wegovy, Novo Nordisk’s newest weight problems drug, for adolescents aged 12 years and older opens up a highly-anticipated instrument within the combat in opposition to childhood weight problems, however some docs warn the sought-after treatment isn’t a magic bullet.
The transfer comes after the FDA accredited Wegovy (semaglutide) for weight administration in adults in 2021.
Proceed to STAT+ to learn the total story…
